Gastro Health, Salix Pharmaceuticals & more — 7 GI company key notes

Here are seven updates on GI companies from the past week:

Advertisement

Check-Cap’s C-Scan preparation-free colonoscopy alternative delivered promising initial results in its post-CE approval trial.

Miami-based Gastro Health closed its acquisition of Boynton Beach-based South Florida Gastroenterology Associates, rebranding the practice’s several locations under the Gastro Health banner.

Cantel Medical is leaving Little Falls, N.J., behind for Plymouth, Minn.

Fujifilm Corp. invested an undisclosed amount in Suono Bio to support the company’s second-generation drug pipeline.

PvP Biologics is conducting the first in-human clinical trials for its celiac disease drug candidate Kuma062.

Salix Pharmaceuticals launched Plenvu, a one-liter prescription bowel preparation solution.

Provation launched an advanced software feature for automating physician adenoma detection rate calculation and reporting.

More articles on gastroenterology:
Crohn’s & Colitis Foundation chapter names Dr. Steven Brown Humanitarian of the Year — 3 insights
New AGA grant encourages diverse workforce development — 5 insights
Takeda closing US headquarters, 1K workers potentially affected — 6 insights

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.